BioSymetrics is a phenomics-driven drug discovery founded in 2015 by Anthony Iacovone.
1
Funding Rounds
$5.9m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Name | Phone | Social networks | |
---|---|---|---|
An***** Ia****** |
|
- | |
Ga***** Mu*** | - | - | - |